Document Detail


Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn.
MedLine Citation:
PMID:  1502009     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An increased risk of seizures during and immediately after labour has been observed in epileptic women, and it is recognized that serum levels of antiepileptic drugs may decrease in pregnancy. Several studies have suggested that total valproate levels fall, but that free fractions increase during pregnancy. Recent findings suggest that the actual metabolism of valproate is not altered by pregnancy and that the changes of the plasma clearance are due primarily to decreased protein binding. The levels of free drug will not change significantly as pregnancy advances. However, dose reduction after delivery may be necessary to avoid toxicity. Valproate and its metabolites undergo placental transfer. In the foetus the plasma level of valproate and the protein binding are higher than in maternal plasma, and the half-life of valproate following placental transfer is considerably longer than in adults. Only small amounts of valproate appear in breast milk and those are not likely to cause any problems. During pregnancy and the first month after delivery preferably both total and free valproate serum levels should be closely monitored to determine the lowest effective dose.
Authors:
S I Johannessen
Related Documents :
20868679 - Feasibility of fetal-derived hypermethylated rassf1a sequence quantification in materna...
1340439 - Pregnancy alters the hemodynamic responses to cocaine in the rat.
18938289 - First-trimester maternal plasma concentrations of c-reactive protein in low-risk patien...
1442979 - Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies.
2398459 - Pharmacokinetics of zidovudine (azidothymidine). i. transplacental transfer.
15175799 - Levels of annexin iv and v in the plasma of pregnant and postpartum women.
10320309 - Echogenicity of fetal lung and liver quantified by the grey-level histogram width.
15747809 - A prospective study of the short-term treatment effects of the acrylic-splint rapid max...
16516289 - Twin anemia-polycythemia sequence in two monochorionic twin pairs without oligo-polyhyd...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pharmaceutisch weekblad. Scientific edition     Volume:  14     ISSN:  0167-6555     ISO Abbreviation:  Pharm Weekbl Sci     Publication Date:  1992 Jun 
Date Detail:
Created Date:  1992-09-14     Completed Date:  1992-09-14     Revised Date:  2008-02-25    
Medline Journal Info:
Nlm Unique ID:  7907992     Medline TA:  Pharm Weekbl Sci     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  114-7     Citation Subset:  IM    
Affiliation:
National Centre for Epilepsy, Sandvika, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticonvulsants / administration & dosage,  pharmacology
Drug Interactions
Drug Monitoring
Female
Fetus / metabolism
Humans
Infant, Newborn
Maternal-Fetal Exchange
Milk, Human / metabolism
Pregnancy / metabolism*
Protein Binding
Tissue Distribution
Valproic Acid / metabolism,  pharmacokinetics*
Chemical
Reg. No./Substance:
0/Anticonvulsants; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of co-medication on the metabolism of valproate.
Next Document:  Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.